Prof. Dr. Ambros J. Beer

Mole­ku­lare Bild­ge­bung, Hybrid­bild­ge­bung inkl. PET/MR und PET/CT, ima­ging of angio­ge­ne­sis

• “Image of the year”, Jah­res­ta­gung der DGN 2004, Ros­tock
• “Young Inves­ti­ga­tor Award for the Year 2005“ der „Society for the Advance­ment of Nuclear Medi­cine at the Tech­ni­sche Uni­ver­si­tät Mün­chen”
• 2005 First Place Award “Out­stan­ding Cli­ni­cal Inves­ti­ga­ti­ons” des Jour­nal of Nuclear Medi­cine. Jah­res­ta­gung SNM 2006, San Diego
• 2007 bes­tes kli­ni­sches Paper (3. Platz) des Young Pro­fes­sio­nals Com­mit­tee der Society for Nuclear Medi­cine. Jah­res­ta­gung SNM 2007, Washing­ton
• Best­plat­zie­rung “Car­dio­va­s­cu­lar sci­en­ces young inves­ti­ga­tor award sym­po­sium” Jah­res­ta­gung SNM 2008, New Orleans
• Ehren­preis 2008 der Baye­ri­schen Rönt­gen­ge­sell­schaft: “Visua­liza­tion of antigen-​specific human cyto­to­xic T lym­pho­cy­tes labe­led with super­pa­ra­ma­gne­tic iron-​oxide par­ticles”
• Ehren­preis 2008 der Baye­ri­schen Rönt­gen­ge­sell­schaft: “Magne­tic Reso­nance Ima­ging in Pati­ents with Rec­tal Can­cer before Neo­ad­ju­vant Che­mo­ra­dio­the­rapy for Pre­dic­tion of Tumor-​Free Cir­cum­fe­ren­tial Resec­tion Mar­gins and Long-​Term Sur­vi­val”
• Mole­cu­lar Ima­ging Tra­vel Award der RSNA für die Ver­öf­fent­li­chung "PET-​MRI Cor­re­la­tion of Diffusion-​weighted MR Ima­ging and 11C-​Choline PET/CT for Cha­rac­te­riza­tion of Pel­vic Lymph Node Meta­sta­ses in Pati­ents with Pro­state Can­cer"; Jah­res­ta­gung RSNA 2009, Chi­cago
• Mole­cu­lar Ima­ging Cen­ter of Excel­lence Young inves­ti­ga­tor award (2. Platz). Jah­res­ta­gung SNM 2010, Salt Lake City

• Prä­si­dent der Süd­west­deut­schen Gesell­schaft für Nukle­ar­me­di­zin (seit 11/2020)
• Deut­sche Gesell­schaft für Nukle­ar­me­di­zin (DGN)
• European Asso­cia­tion of Nuclear Medi­cine (EANM)
• Deut­sche Rönt­gen­ge­sell­schaft
• Society of Nuclear Medi­cine (SNM)
• Radio­lo­gi­cal Society of North Ame­rica (RSNA)

• Inter­na­tio­nal Advi­sory Board “The Lan­cet Onco­logy”
• EJN­MMI Rese­arch
• Wis­sen­schaft­li­cher Bei­rat „Der Nukle­ar­me­di­zi­ner“
• Tomo­gra­phy
• European Radio­logy (2010-2016)
• The Open Medi­cal Ima­ging Jour­nal

• Mit­glied des Aus­schus­ses „Cli­ni­cal Qua­lity Manage­ment“ der DGN

• EORTC Pro­to­col Review Aus­schuss

• SNMMI PET/MRI Task Force

Gut­ach­ter für wis­sen­schaft­li­che Orga­ni­sa­tio­nen

• Can­cer Rese­arch UK

• Deut­sche For­schungs­ge­mein­schaft DFG

• Deut­sche Krebs­hilfe

• FWF Fonds zur För­de­rung der wis­sen­schaft­li­chen For­schung (Öster­reich)

• Man­ches­ter Can­cer Rese­arch Centre MCRC

• Medi­cal Rese­arch Coun­cil MRC

• Medi­zi­ni­sche Uni­ver­si­tät Wien

• Ministère de l’Ens­eig­ne­ment supérieur et de la Recher­che (Fran­zö­si­sches Minis­te­rium für Bil­dung und For­schung)

• Pan­crea­tic Can­cer UK PCUK

• Swiss Natio­nal Sci­ence Founda­tion SNSF

• Wil­helm Sander-​Stiftung

Bei Kon­gres­sen

• World Mole­cu­lar Ima­ging Con­fe­rence WMIC

• Jah­res­ta­gung der Society of Nuclear Medi­cine and Mole­cu­lar Ima­ging SNMMI

• European Con­gress of Radio­logy

• Jah­res­ta­gung der Deut­schen Gesell­schaft für Nukle­ar­me­di­zin DGN

für wis­sen­schaft­li­che Jour­nale

Aca­de­mic Radio­logy, Ame­ri­can Jour­nal of Respi­ra­tory and Cri­ti­cal Care Medi­cine, Ame­ri­can Jour­nal of Roent­ge­no­logy AJR, AJR Inte­gra­tive Ima­ging, Amino Acids, Angio­ge­ne­sis Reviews, Annals of Nuclear Medi­cine, Bio­con­ju­gate Che­mis­try, BMC Can­cer, Bri­tish Jour­nal of Can­cer, Can­cer Ima­ging, Can­cer Let­ters, Can­cer Rese­arch, Cir­cu­la­tion, Cli­ni­cal Can­cer Rese­arch, Com­pu­ters in Bio­logy and Medi­cine, Cur­rent Nano­sci­ence, Cur­rent Phar­maceu­ti­cal Design, European Jour­nal of Hema­to­logy, European Jour­nal of Nuclear Medi­cine and Mole­cu­lar Ima­ging, European Jour­nal of Nuclear Medi­cine and Mole­cu­lar Ima­ging Rese­arch, European Radio­logy, Expert Review of Medi­cal Devices, Expert Review of Antican­cer The­rapy, Ima­ging in Medi­cine, Inter­na­tio­nal Jour­nal of Can­cer, Inves­ti­ga­tive Radio­logy, Jour­nal of Cli­ni­cal Endocri­no­logy & Meta­bo­lism, Jour­nal of Magne­tic Reso­nance Ima­ging, Jour­nal of Nuclear Medi­cine, Jour­nal of Post­gra­duate Medi­cine, Jour­nal of Sur­gi­cal Onco­logy, Lan­cet Onco­logy, Lung Can­cer Inter­na­tio­nal, Medi­cinal Rese­arch Reviews, Mole­cu­lar Ima­ging, Mole­cu­lar Ima­ging and Bio­logy, Mole­cu­lar Phar­maceu­tics, Nature Reviews Onco­logy, Nuclear Medi­cine and Bio­logy, Nuclear Medi­cine Com­mu­ni­ca­ti­ons, Nukle­ar­me­di­zin, Onco­tar­get, PLoS One, Radio­loge, The­r­a­no­stics, World Jour­nal of Radio­logy, Yonsei Medi­cal Jour­nal

• Lis­son CS, Lis­son CG, Flos­dorf K, Mayer-​Steinacker R, Schult­heiss M, von Baer A, Barth TFE, Beer AJ, Baum­hauer M, Meier R, Beer M, Schmidt SA. Dia­gno­stic value of MRI-​based 3D tex­ture ana­ly­sis for tis­sue cha­rac­te­ri­sa­tion and discri­mi­na­tion of low-​grade chon­dro­sar­coma from enchon­droma: a pilot study. Eur Radiol. 2017 Sep 7. [Epub ahead of print]

• Eiber M, Rauscher I, Sou­vatzoglou M, Mau­rer T, Schwai­ger M, Holz­ap­fel K, Beer AJ. Pro­spec­tive head-​to-head com­pa­ri­son of 11C-​choline-PET/MR and 11C-​choline-PET/CT for res­ta­ging of bio­che­mi­cal recur­rent pro­state can­cer. Eur J Nucl Med Mol Ima­ging. 2017 Aug 12. [Epub ahead of print]

• Kra­mer L, Win­ter G, Baur B, Kuntz AJ, Kull T, Sol­bach C, Beer AJ, Lindén M. Quan­ti­ta­tive and cor­re­la­tive bio­dis­tri­bu­tion ana­ly­sis of 89Zr-​labeled meso­porous silica nano­par­ticles intra­venously injec­ted into tumor-​bearing mice. Nanos­cale. 2017 Jul 13;9(27):9743-9753.

• Weber T, Gott­stein M, Schwen­zer S, Beer A, Lus­ter M. Is C-11 Methio­nine PET/CT Able to Loca­lise Sestamibi-​Negative Para­thy­roid Ade­no­mas? World J Surg. 2017 Apr;41(4):980-985.

• Beer AJ, Dijk­graaf I. Edi­to­rial European Jour­nal of Nuclear Medi­cine and Mole­cu­lar Ima­ging. Eur J Nucl Med Mol Ima­ging. 2017 Feb;44(2):284-285.

• O'Con­nor JP, Aboa­gye EO, Adams JE, Aerts HJ, Bar­ring­ton SF, Beer AJ, Boel­laard R, Bohn­diek SE, Brady M, Brown G, Buck­ley DL, Che­ne­vert TL, Clarke LP, Col­lette S, Cook GJ, deSouza NM, Dick­son JC, Dive C, Evel­hoch JL, Faivre-​Finn C, Gal­lag­her FA, Gil­bert FJ, Gil­lies RJ, Goh V, Grif­fiths JR, Groves AM, Hal­ligan S, Har­ris AL, Hawkes DJ, Hoek­s­tra OS, Huang EP, Hut­ton BF, Jack­son EF, Jay­son GC, Jones A, Koh DM, Lacombe D, Lam­bin P, Las­sau N, Leach MO, Lee TY, Leen EL, Lewis JS, Liu Y, Lyth­goe MF, Manoh­a­ran P, Max­well RJ, Miles KA, Mor­gan B, Mor­ris S, Ng T, Padhani AR, Par­ker GJ, Par­tridge M, Pat­hak AP, Peet AC, Pun­wani S, Rey­nolds AR, Robin­son SP, Shan­kar LK, Sharma RA, Solo­viev D, Stroo­bants S, Sul­li­van DC, Tay­lor SA, Tofts PS, Tozer GM, van Herk M, Walker-​Samuel S, Wason J, Wil­liams KJ, Work­man P, Yan­kee­lov TE, Brindle KM, McS­hane LM, Jack­son A, Water­ton JC. Ima­ging bio­mar­ker road­map for can­cer stu­dies. Nat Rev Clin Oncol. 2017 Mar;14(3):169-186.

• Rauscher I, Mau­rer T, Beer AJ, Gra­ner FP, Hal­ler B, Wei­rich G, Doherty A, Gschwend JE, Schwai­ger M, Eiber M. Value of 68Ga-​PSMA HBED-​CC PET for the Assess­ment of Lymph Node Meta­sta­ses in Pro­state Can­cer Pati­ents with Bio­che­mi­cal Recur­rence: Com­pa­ri­son with His­to­pa­tho­logy After Sal­vage Lympha­denec­tomy. J Nucl Med. 2016 Nov;57(11):1713-1719.

• Klet­ting P, Schu­chardt C, Kul­karni HR, Sha­hin­far M, Singh A, Glat­ting G, Baum RP, Beer AJ. Inves­ti­ga­ting the Effect of Ligand Amount and Injec­ted The­ra­peu­tic Acti­vity: A Simu­la­tion Study for 177Lu-​Labeled PSMA-​Targeting Pep­ti­des. PLoS One. 2016 Sep 9;11(9):e0162303.

• Leuzy A, Chio­tis K, Has­sel­balch SG, Rinne JO, de Mendonça A, Otto M, Lleó A, Castelo-​Branco M, San­tana I, Johans­son J, Anderl-​Straub S, von Arnim CA, Beer A, Blesa R, For­tea J, Herukka SK, Por­te­lius E, Pannee J, Zet­ter­berg H, Blen­now K, Nord­berg A. Pitts­burgh com­pound B ima­ging and cere­bro­s­pi­nal fluid amyloid-​β in a mul­ti­centre European memory cli­nic study. Brain. 2016 Sep;139(Pt 9):2540-53.

• Rauscher I, Mau­rer T, Sou­vatzoglou M, Beer AJ, Vag T, Wirtz M, Wei­rich G, Wes­ter HJ, Gschwend JE, Schwai­ger M, Schot­telius M, Eiber M. Intra­pa­ti­ent Com­pa­ri­son of 111In-​PSMA I&T SPECT/CT and Hybrid 68Ga-​HBED-CC PSMA PET in Pati­ents With Early Recur­rent Pro­state Can­cer. Clin Nucl Med. 2016 Sep;41(9):e397-402.

• Beer AJ, Schwar­zen­böck SM, Zantl N, Sou­vatzoglou M, Mau­rer T, Watz­lo­wik P, Kess­ler H, Wes­ter HJ, Schwai­ger M, Krause BJ. Non-​invasive assess­ment of inter-​and intra­pa­ti­ent varia­bi­lity of inte­grin expres­sion in metasta­si­zed pro­state can­cer by PET. Onco­tar­get. 2016 May 10;7(19):28151-9.

• Taouli B, Beer AJ, Che­ne­vert T, Col­lins D, Leh­man C, Matos C, Padhani AR, Rosen­krantz AB, Shukla-​Dave A, Sig­mund E, Tanen­baum L, Thoeny H, Thomassin-​Naggara I, Bar­bieri S, Corcuera-​Solano I, Orton M, Par­tridge SC, Koh DM. Diffusion-​weighted ima­ging out­side the brain: Con­sen­sus state­ment from an ISMRM-​sponsored work­shop. J Magn Reson Ima­ging. 2016 Sep;44(3):521-40.

• Eiber M, Wei­rich G, Holz­ap­fel K, Sou­vatzoglou M, Hal­ler B, Rauscher I, Beer AJ, Wes­ter HJ, Gschwend J, Schwai­ger M, Mau­rer T. Simul­ta­neous 68Ga-​PSMA HBED-​CC PET/MRI Improves the Loca­liza­tion of Pri­mary Pro­state Can­cer. Eur Urol. 2016 Nov;70(5):829-836.

• Crön­lein M, Rauscher I, Beer AJ, Schwai­ger M, Sch­äf­feler C, Bei­rer M, Huber S, Sand­mann GH, Biber­tha­ler P, Eiber M, Kirch­hoff C. Visua­liza­tion of stress frac­tu­res of the foot using PET-​MRI: a fea­si­bi­lity study. Eur J Med Res. 2015 Dec 23;20:99.

• Mau­rer T, Gschwend JE, Rauscher I, Sou­vatzoglou M, Hal­ler B, Wei­rich G, Wes­ter HJ, Heck M, Küb­ler H, Beer AJ, Schwai­ger M, Eiber M. Dia­gno­stic Effi­cacy of (68)Gallium-​PSMA Posi­tron Emis­sion Tomo­gra­phy Com­pa­red to Con­ven­tio­nal Ima­ging for Lymph Node Sta­ging of 130 Con­se­cu­tive Pati­ents with Inter­me­diate to High Risk Pro­state Can­cer. J Urol. 2016 May;195(5):1436-43.

• Klet­ting P, Kull T, Maaß C, Malik N, Lus­ter M, Beer AJ, Glat­ting G. Opti­mi­zed Pep­tide Amount and Acti­vity for ⁹⁰Y-​Labeled DOTA­TATE The­rapy. J Nucl Med. 2016 Apr;57(4):503-8.

• D'Ales­sandria C, Pohle K, Rechen­ma­cher F, Neu­bauer S, Notni J, Wes­ter HJ, Schwai­ger M, Kess­ler H, Beer AJ. In vivo bio­ki­ne­tic and meta­bo­lic cha­rac­te­riza­tion of the 68Ga-​labelled α5β1-​selective pep­ti­do­mime­tic FR366. Eur J Nucl Med Mol Ima­ging. 2015 Oct 24

• Metz S, Gan­ter C, Loren­zen S, van Mar­wick S, Holz­ap­fel K, Herr­mann K, Rum­meny EJ, Wes­ter HJ, Schwai­ger M, Nekolla SG, Beer AJ. Mul­ti­pa­ra­me­tric MR and PET Ima­ging of Intra­tu­mo­ral Bio­lo­gi­cal Hete­ro­gen­eity in Pati­ents with Meta­sta­tic Lung Can­cer Using Voxel-​by-Voxel Ana­ly­sis. PLoS One. 2015 Jul 17;10(7):

• Meier R, Bra­ren R, Kosanke Y, Bus­se­mer J, Neff F, Wild­gru­ber M, Schwar­zen­böck S, Frank A, Hal­ler B, Hohl­baum AM, Schwai­ger M, Gille H, Rum­meny EJ, Beer AJ. Mul­ti­moda­lity mul­ti­pa­ra­me­tric ima­ging of early tumor response to a novel anti­an­gio­ge­nic the­rapy based on anti­ca­lins. PLoS One. 2014 May 6;9(5

• Trajkovic-​Arsic M, Moha­jerani P, Saran­to­pou­los A, Kali­de­ris E, Stei­ger K, Espo­sito I, Ma X, The­me­lis G, Bur­ton N, Michal­ski CW, Kleeff J, Stangl S, Beer AJ, Pohle K, Wes­ter HJ, Schmid RM, Bra­ren R, Ntzia­chris­tos V, Siveke JT. Mul­ti­modal mole­cu­lar ima­ging of inte­grin αvβ3 for in vivo detec­tion of pan­crea­tic can­cer. J Nucl Med. 2014 Mar;55(3):446-51

• Beer AJ, Peli­sek J, Hei­der P, Saraste A, Reeps C, Metz S, Seidl S, Kess­ler H, Wes­ter HJ, Eck­stein HH, Schwai­ger M.PET/CT ima­ging of inte­grin αvβ3 expres­sion in human caro­tid athe­ros­cle­ro­sis. JACC Car­dio­vasc Ima­ging. 2014 Feb;7(2):178-87

• Eiber M, Takei T, Sou­vatzoglou M, Mayerhoe­fer ME, Fürst S, Gaert­ner FC, Loef­fel­bein DJ, Rum­meny EJ, Zieg­ler SI, Schwai­ger M, Beer AJ. Per­for­mance of whole-​body inte­gra­ted 18F-FDG PET/MR in com­pa­ri­son to PET/CT for eva­lua­tion of mali­gnant bone lesi­ons. J Nucl Med. 2014 Feb;55(2):191-7

• Neu­bauer S, Rechen­ma­cher F, Beer AJ, Cur­nis F, Pohle K, D'Ales­sandria C, Wes­ter HJ, Reu­ning U, Corti A, Schwai­ger M, Kess­ler H. Sel­ec­tive ima­ging of the angio­ge­nic rele­vant inte­grins α5β1 and αvβ3. Angew Chem Int Ed Engl. 2013 Oct 25;52(44):11656-9

• Martinez-​Möller A, Eiber M, Nekolla SG, Sou­vatzoglou M, Drzezga A, Zieg­ler S, Rum­meny EJ, Schwai­ger M, Beer AJ. Work­flow and scan pro­to­col con­side­ra­ti­ons for inte­gra­ted whole-​body PET/MRI in onco­logy. J Nucl Med. 2012 Sep;53(9):1415-26

• Beer AJ, Eiber M, Sou­vatzoglou M, Schwai­ger M, Krause BJ. Radio­nuclide and hybrid ima­ging of recur­rent pro­state can­cer. Lan­cet Oncol. 2011 Feb;12(2):181-91

• Beer AJ, Grosu AL, Carl­sen J, Kolk A, Sar­bia M, Stan­gier I, Watz­lo­wik P, Wes­ter HJ, Haub­ner R, Schwai­ger M. [18F]galacto-​RGD posi­tron emis­sion tomo­gra­phy for ima­ging of alphav­beta3 expres­sion on the neo­va­s­cu­la­ture in pati­ents with squa­mous cell car­ci­noma of the head and neck. Clin Can­cer Res. 2007 Nov 15;13(22 Pt 1):6610-6